GLYPICAN 3 targeted therapy in pediatric solid malignant tumors.
Project/Area Number |
22591980
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatric surgery
|
Research Institution | Kyushu University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
TAGUCHI Tomoaki 九州大学, 医学研究院, 教授 (20197247)
TAJIRI Tatsuro 京都府立医科大学, 医学研究科, 教授 (80304806)
SUZAKI Ryota 九州大学, 大学病院, 助教 (10403990)
TANAKA Sakura 九州大学, 医学研究院, 共同研究員 (40467923)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | GLYPICAN3 / 小児固形悪性腫瘍 / 腫瘍マーカー / AFP / 分子標的治療 |
Research Abstract |
【Purpose】The purpose of this study is to analyze the usefulness of Glypican3 as a novel diagnostic tumor marker for pediatric solid malignant tumor, and to establish the new diagnostic system. Final goal is to develop the immuno-genetic therapy targeted for the Glypican3.【Method】The immunohistochemical analysis and serological analysis of Glypican3 and AFP was performed for the pathological materials and patient’s serum. 【Results】Immunohistochemlically and serologically, most cases of hepatoblastoma and malignant germ cell tumor showed positive for Glypican3, and one of thirds Wilms tumor, alveolar type rhabdomyosarcoma and undifferentiated sarcoma were also positive. Concerning AFP, most cases of hepatoblastoma and malignant germ cell tumor showed positive. Concerning non-neoplastic patients’, serum Glypican 3 was high just after birth and gradually decreased according to their age. The level normalized by the 1 year.【Discussion】Glypican3 was confirmed as the novel diagnostic marker for pediatric solid malignant tumors. Based on this research, for the refractory cases of pediatric solid malignant tumor over 1 year, such new treatment immuno-genetic therapy targeted forGlypican 3 will be expected.
|
Report
(4 results)
Research Products
(25 results)
-
-
[Journal Article] The prognostic significance of blastemal predominant histology in initially resected Wilms'tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan2012
Author(s)
Kinoshita Y, Suminoe A, Inada H, Yagi M, Yanai F, Zaizen Y, Nishi M, Inomata Y, Kawakami K, Matsufuji H, Suenobu S, Handa N, Kohashi K, Oda Y, Hara T, Taguchi T
-
Journal Title
J Pediatr Surg
Volume: 47
Issue: 12
Pages: 2205-2209
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Successful resection of an undifferentiated sarcoma in a child using a real-time surgical navigation system in an open magnetic resonance imaging operation room2011
Author(s)
Souzaki R, Kinoshita Y, Matsuura T, Tajiri T, Taguchi T, Ieiri S, Hong J, Uemura M, Konishi K, Tomikawa M, Tanoue K, Hashizume M, Koga Y, Suminoe A, Hara T, Kohashi K, et al
-
Journal Title
J Pediatr Surg
Volume: 46
Issue: 3
Pages: 608-611
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] 肝移植のタイミングに難渋した巨大肝芽腫の1例2010
Author(s)
高橋由紀子, 西本祐子, 松浦俊治, 林田真, 田尻達郎, 増本幸二, 藤田桂子, 木下義晶, 宗崎良太, 武冨紹信, 前原喜彦, 猪股裕紀洋, 田口智章
-
Journal Title
臨床と研究
Volume: 87
Pages: 1288-1289
Related Report
Peer Reviewed
-
[Journal Article] 樹状細胞療法を施行した小児腎細胞癌の1例2010
Author(s)
竜田恭介, 木下義晶, 田尻達郎, 中辻隆徳, 東真弓, 宗崎良太, 江藤正俊, 立神勝則, 孝橋賢一, 内藤誠二, 恒吉正澄, 田口智章
-
Journal Title
小児がん
Volume: 47
Pages: 441-446
NAID
URL
Related Report
Peer Reviewed
-
[Journal Article] Concordance for neuroblastoma in monozygotic twins: case report and review of the literature2010
Author(s)
Tajiri T, Souzaki R, Kinoshita Y, Tanaka S, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Masumoto K, Ohira M, Nakagawara A, Taguchi T
-
Journal Title
J Pediatr Surg
Volume: 45
Issue: 12
Pages: 2312-2316
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-